Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 4:35 PM
Ignite Modification Date:
2025-12-25 @ 2:26 PM
NCT ID:
NCT00072566
Group ID:
EG000
Title:
Treatment (Bevacizumab, Cyclophosphamide)
Description:
Patients receive 10 mg/kg bevacizumab IV over 30-90 minutes on days 1, 8, and 15 for the first course and on days 1 and 15 for all subsequent courses. Patients also receive low-dose oral cyclophosphamide 50 mg/d on days 1-28. Courses repeat every 28 days in the absence of disease progression or unacceptable toxicity.
bevacizumab: Given IV
cyclophosphamide: Given PO
Deaths Number Affected:
None
Deaths Number At Risk:
None
Serious Number Affected:
23
Serious Number At Risk:
70
Other Number Affected:
70
Other Number At Risk:
70
Study:
NCT00072566
Results Section:
NCT00072566
Adverse Events Module:
NCT00072566